The rising prevalence in GLP-1 medications for metabolic conditions has led to a debate about application forms : skin-applied devices versus tablets . Traditionally , GLP-1 therapies were solely https://jimizkp400921.jaiblogs.com/68020534/glp-1-skin-applications-vs-tablets-is-best-for-the-patient